IL-22 is upregulated in patients with psoriatic lesions and previous studies in imiquimod-induced psoriasis mouse models have reported reduced skin lesions in IL-22-deficient mice, indicating the importance of this cytokine in immune-related skin diseases. The gene discussed is IL22; the disease is psoriasis.